nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Epirubicin—breast cancer	0.123	0.519	CrCtD
Idarubicin—Doxorubicin—breast cancer	0.114	0.481	CrCtD
Idarubicin—Anthracyclines—Epirubicin—breast cancer	0.0663	0.205	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Irinotecan—breast cancer	0.0641	0.199	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Mitoxantrone—breast cancer	0.0641	0.199	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—breast cancer	0.0613	0.19	CiPCiCtD
Idarubicin—ABCC1—breast cancer	0.0592	0.481	CbGaD
Idarubicin—TOP2A—breast cancer	0.0457	0.371	CbGaD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.0346	0.107	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—breast cancer	0.032	0.0994	CiPCiCtD
Idarubicin—Valrubicin—Epirubicin—breast cancer	0.0261	0.173	CrCrCtD
Idarubicin—Doxorubicin—Epirubicin—breast cancer	0.0261	0.173	CrCrCtD
Idarubicin—Daunorubicin—Epirubicin—breast cancer	0.0261	0.173	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—breast cancer	0.0242	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—breast cancer	0.0242	0.16	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—breast cancer	0.0242	0.16	CrCrCtD
Idarubicin—CYP2D6—breast cancer	0.0182	0.148	CbGaD
Idarubicin—TOP2A—Mitoxantrone—breast cancer	0.0158	0.15	CbGbCtD
Idarubicin—TOP2A—Epirubicin—breast cancer	0.0128	0.121	CbGbCtD
Idarubicin—ABCC1—Mitoxantrone—breast cancer	0.00876	0.0831	CbGbCtD
Idarubicin—ABCC1—Epirubicin—breast cancer	0.00709	0.0673	CbGbCtD
Idarubicin—ABCC1—Paclitaxel—breast cancer	0.00699	0.0663	CbGbCtD
Idarubicin—ABCC1—Irinotecan—breast cancer	0.0069	0.0654	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—breast cancer	0.0068	0.0645	CbGbCtD
Idarubicin—CYP2C9—Anastrozole—breast cancer	0.00668	0.0634	CbGbCtD
Idarubicin—ABCC1—Vinblastine—breast cancer	0.00613	0.0582	CbGbCtD
Idarubicin—ABCC1—Docetaxel—breast cancer	0.00505	0.048	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—breast cancer	0.00377	0.0358	CbGbCtD
Idarubicin—ABCC1—Methotrexate—breast cancer	0.00365	0.0346	CbGbCtD
Idarubicin—CYP2C9—Capecitabine—breast cancer	0.00278	0.0263	CbGbCtD
Idarubicin—CYP2D6—Vinorelbine—breast cancer	0.00226	0.0215	CbGbCtD
Idarubicin—CYP2C9—Tamoxifen—breast cancer	0.00223	0.0212	CbGbCtD
Idarubicin—CYP2D6—Tamoxifen—breast cancer	0.00204	0.0194	CbGbCtD
Idarubicin—CYP2C9—Paclitaxel—breast cancer	0.00174	0.0165	CbGbCtD
Idarubicin—CYP2C9—Fluorouracil—breast cancer	0.00165	0.0156	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—breast cancer	0.00139	0.0132	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—breast cancer	0.000857	0.00813	CbGbCtD
Idarubicin—Doxorubicin—NDUFS3—breast cancer	0.000225	0.155	CrCbGaD
Idarubicin—TOP2A—nipple—breast cancer	0.000164	0.117	CbGeAlD
Idarubicin—Epirubicin—AURKA—breast cancer	0.000163	0.112	CrCbGaD
Idarubicin—Valrubicin—TOP2A—breast cancer	0.00015	0.103	CrCbGaD
Idarubicin—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000112	0.145	CbGdCrCtD
Idarubicin—TOP2A—Gefitinib—Lapatinib—breast cancer	0.00011	0.142	CbGdCrCtD
Idarubicin—Epirubicin—PLA2G4A—breast cancer	0.000105	0.0721	CrCbGaD
Idarubicin—TOP2A—endometrium—breast cancer	9.91e-05	0.0706	CbGeAlD
Idarubicin—ABCC1—nipple—breast cancer	9.89e-05	0.0704	CbGeAlD
Idarubicin—Doxorubicin—AURKA—breast cancer	9.35e-05	0.0643	CrCbGaD
Idarubicin—TOP2A—uterus—breast cancer	9.14e-05	0.065	CbGeAlD
Idarubicin—CYP2C9—mammary gland—breast cancer	9.04e-05	0.0644	CbGeAlD
Idarubicin—TOP2A—adipose tissue—breast cancer	8.94e-05	0.0636	CbGeAlD
Idarubicin—Epirubicin—ABCC1—breast cancer	8.48e-05	0.0583	CrCbGaD
Idarubicin—TOP2A—adrenal gland—breast cancer	8.02e-05	0.0571	CbGeAlD
Idarubicin—TOP2A—Topotecan—Irinotecan—breast cancer	7.97e-05	0.103	CbGdCrCtD
Idarubicin—TOP2A—bone marrow—breast cancer	7.75e-05	0.0552	CbGeAlD
Idarubicin—TOP2A—female gonad—breast cancer	7.47e-05	0.0532	CbGeAlD
Idarubicin—TOP2A—Vindesine—Vinorelbine—breast cancer	7.12e-05	0.0924	CbGdCrCtD
Idarubicin—Epirubicin—TOP2A—breast cancer	6.54e-05	0.045	CrCbGaD
Idarubicin—Daunorubicin—ABCC1—breast cancer	6e-05	0.0412	CrCbGaD
Idarubicin—ABCC1—endometrium—breast cancer	5.97e-05	0.0425	CbGeAlD
Idarubicin—TOP2A—Vindesine—Vinblastine—breast cancer	5.7e-05	0.0739	CbGdCrCtD
Idarubicin—TOP2A—Paclitaxel—Docetaxel—breast cancer	5.59e-05	0.0725	CbGdCrCtD
Idarubicin—ABCC1—uterus—breast cancer	5.5e-05	0.0392	CbGeAlD
Idarubicin—ABCC1—pituitary gland—breast cancer	5.4e-05	0.0385	CbGeAlD
Idarubicin—ABCC1—adipose tissue—breast cancer	5.38e-05	0.0383	CbGeAlD
Idarubicin—Doxorubicin—NQO1—breast cancer	5.37e-05	0.0369	CrCbGaD
Idarubicin—Doxorubicin—ABCC1—breast cancer	4.87e-05	0.0335	CrCbGaD
Idarubicin—ABCC1—adrenal gland—breast cancer	4.83e-05	0.0344	CbGeAlD
Idarubicin—TOP2A—lymph node—breast cancer	4.8e-05	0.0342	CbGeAlD
Idarubicin—Daunorubicin—TOP2A—breast cancer	4.63e-05	0.0318	CrCbGaD
Idarubicin—Daunorubicin—CYP1B1—breast cancer	4.59e-05	0.0315	CrCbGaD
Idarubicin—Doxorubicin—NOS3—breast cancer	4.54e-05	0.0312	CrCbGaD
Idarubicin—ABCC1—female gonad—breast cancer	4.5e-05	0.032	CbGeAlD
Idarubicin—Doxorubicin—NOS2—breast cancer	4.38e-05	0.0301	CrCbGaD
Idarubicin—TOP2A—Vincristine—Vinorelbine—breast cancer	3.84e-05	0.0498	CbGdCrCtD
Idarubicin—Doxorubicin—TOP2A—breast cancer	3.76e-05	0.0258	CrCbGaD
Idarubicin—CYP2C9—female reproductive system—breast cancer	3.74e-05	0.0266	CbGeAlD
Idarubicin—Doxorubicin—CYP1B1—breast cancer	3.72e-05	0.0256	CrCbGaD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—breast cancer	3.59e-05	0.0466	CbGdCrCtD
Idarubicin—CYP2C9—endocrine gland—breast cancer	3.17e-05	0.0225	CbGeAlD
Idarubicin—Daunorubicin—ABCG2—breast cancer	3.16e-05	0.0217	CrCbGaD
Idarubicin—TOP2A—Vinblastine—Vinorelbine—breast cancer	3.09e-05	0.0401	CbGdCrCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—breast cancer	3.07e-05	0.0398	CbGdCrCtD
Idarubicin—ABCC1—lymph node—breast cancer	2.89e-05	0.0206	CbGeAlD
Idarubicin—CYP2D6—female reproductive system—breast cancer	2.81e-05	0.02	CbGeAlD
Idarubicin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	2.59e-05	0.0336	CbGdCrCtD
Idarubicin—Doxorubicin—ABCG2—breast cancer	2.57e-05	0.0176	CrCbGaD
Idarubicin—CYP2D6—female gonad—breast cancer	2.55e-05	0.0182	CbGeAlD
Idarubicin—Daunorubicin—CYP1A1—breast cancer	2.48e-05	0.017	CrCbGaD
Idarubicin—CYP2D6—endocrine gland—breast cancer	2.38e-05	0.0169	CbGeAlD
Idarubicin—TOP2A—Cytarabine—Gemcitabine—breast cancer	2.02e-05	0.0262	CbGdCrCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—breast cancer	1.87e-05	0.0243	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—breast cancer	1.87e-05	0.0243	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—breast cancer	1.73e-05	0.0225	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—breast cancer	1.73e-05	0.0225	CbGdCrCtD
Idarubicin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	1.69e-05	0.0219	CbGdCrCtD
Idarubicin—Daunorubicin—CYP3A4—breast cancer	1.58e-05	0.0109	CrCbGaD
Idarubicin—Doxorubicin—CYP2D6—breast cancer	1.5e-05	0.0103	CrCbGaD
Idarubicin—TOP2A—Azacitidine—Gemcitabine—breast cancer	1.45e-05	0.0188	CbGdCrCtD
Idarubicin—Daunorubicin—ABCB1—breast cancer	1.32e-05	0.00905	CrCbGaD
Idarubicin—Doxorubicin—CYP3A4—breast cancer	1.28e-05	0.00882	CrCbGaD
Idarubicin—Dehydration—Epirubicin—breast cancer	1.23e-05	0.000274	CcSEcCtD
Idarubicin—Immune system disorder—Docetaxel—breast cancer	1.23e-05	0.000273	CcSEcCtD
Idarubicin—Rash—Melphalan—breast cancer	1.22e-05	0.000272	CcSEcCtD
Idarubicin—Flushing—Capecitabine—breast cancer	1.22e-05	0.000271	CcSEcCtD
Idarubicin—Dermatitis—Melphalan—breast cancer	1.22e-05	0.000271	CcSEcCtD
Idarubicin—Chills—Docetaxel—breast cancer	1.22e-05	0.000271	CcSEcCtD
Idarubicin—Decreased appetite—Mitoxantrone—breast cancer	1.22e-05	0.00027	CcSEcCtD
Idarubicin—Decreased appetite—Irinotecan—breast cancer	1.22e-05	0.00027	CcSEcCtD
Idarubicin—Arrhythmia—Docetaxel—breast cancer	1.22e-05	0.00027	CcSEcCtD
Idarubicin—Nausea—Vinblastine—breast cancer	1.21e-05	0.000269	CcSEcCtD
Idarubicin—Convulsion—Paclitaxel—breast cancer	1.21e-05	0.000269	CcSEcCtD
Idarubicin—Vomiting—Goserelin—breast cancer	1.2e-05	0.000267	CcSEcCtD
Idarubicin—Alopecia—Docetaxel—breast cancer	1.2e-05	0.000267	CcSEcCtD
Idarubicin—Angiopathy—Capecitabine—breast cancer	1.2e-05	0.000265	CcSEcCtD
Idarubicin—Rash—Goserelin—breast cancer	1.19e-05	0.000265	CcSEcCtD
Idarubicin—Hypersensitivity—Thiotepa—breast cancer	1.19e-05	0.000265	CcSEcCtD
Idarubicin—Dermatitis—Goserelin—breast cancer	1.19e-05	0.000265	CcSEcCtD
Idarubicin—Immune system disorder—Capecitabine—breast cancer	1.19e-05	0.000264	CcSEcCtD
Idarubicin—Chest pain—Paclitaxel—breast cancer	1.19e-05	0.000264	CcSEcCtD
Idarubicin—Headache—Goserelin—breast cancer	1.19e-05	0.000263	CcSEcCtD
Idarubicin—Malnutrition—Docetaxel—breast cancer	1.18e-05	0.000263	CcSEcCtD
Idarubicin—Decreased appetite—Gemcitabine—breast cancer	1.18e-05	0.000263	CcSEcCtD
Idarubicin—Chills—Capecitabine—breast cancer	1.18e-05	0.000262	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	1.18e-05	0.000262	CcSEcCtD
Idarubicin—Nausea—Tamoxifen—breast cancer	1.18e-05	0.000261	CcSEcCtD
Idarubicin—Arrhythmia—Capecitabine—breast cancer	1.18e-05	0.000261	CcSEcCtD
Idarubicin—Decreased appetite—Fluorouracil—breast cancer	1.16e-05	0.000258	CcSEcCtD
Idarubicin—Alopecia—Capecitabine—breast cancer	1.16e-05	0.000258	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—breast cancer	1.16e-05	0.000258	CcSEcCtD
Idarubicin—Diarrhoea—Vinorelbine—breast cancer	1.16e-05	0.000257	CcSEcCtD
Idarubicin—Nausea—Melphalan—breast cancer	1.15e-05	0.000256	CcSEcCtD
Idarubicin—Malnutrition—Capecitabine—breast cancer	1.15e-05	0.000254	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—breast cancer	1.15e-05	0.000254	CcSEcCtD
Idarubicin—Gastrointestinal pain—Irinotecan—breast cancer	1.14e-05	0.000254	CcSEcCtD
Idarubicin—Gastrointestinal pain—Mitoxantrone—breast cancer	1.14e-05	0.000254	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—breast cancer	1.14e-05	0.000253	CcSEcCtD
Idarubicin—Anaphylactic shock—Paclitaxel—breast cancer	1.14e-05	0.000253	CcSEcCtD
Idarubicin—Infection—Paclitaxel—breast cancer	1.13e-05	0.000251	CcSEcCtD
Idarubicin—Nausea—Goserelin—breast cancer	1.12e-05	0.00025	CcSEcCtD
Idarubicin—Shock—Paclitaxel—breast cancer	1.12e-05	0.000249	CcSEcCtD
Idarubicin—Thrombocytopenia—Paclitaxel—breast cancer	1.12e-05	0.000248	CcSEcCtD
Idarubicin—Urticaria—Mitoxantrone—breast cancer	1.11e-05	0.000247	CcSEcCtD
Idarubicin—Diarrhoea—Thiotepa—breast cancer	1.11e-05	0.000246	CcSEcCtD
Idarubicin—Skin disorder—Paclitaxel—breast cancer	1.11e-05	0.000246	CcSEcCtD
Idarubicin—Body temperature increased—Irinotecan—breast cancer	1.11e-05	0.000245	CcSEcCtD
Idarubicin—Body temperature increased—Mitoxantrone—breast cancer	1.11e-05	0.000245	CcSEcCtD
Idarubicin—Abdominal pain—Mitoxantrone—breast cancer	1.11e-05	0.000245	CcSEcCtD
Idarubicin—Abdominal pain—Irinotecan—breast cancer	1.11e-05	0.000245	CcSEcCtD
Idarubicin—Anaemia—Docetaxel—breast cancer	1.09e-05	0.000243	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—breast cancer	1.09e-05	0.000242	CcSEcCtD
Idarubicin—Anorexia—Paclitaxel—breast cancer	1.09e-05	0.000241	CcSEcCtD
Idarubicin—Vomiting—Vinorelbine—breast cancer	1.08e-05	0.000239	CcSEcCtD
Idarubicin—Body temperature increased—Gemcitabine—breast cancer	1.08e-05	0.000239	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—breast cancer	1.07e-05	0.000238	CcSEcCtD
Idarubicin—Rash—Vinorelbine—breast cancer	1.07e-05	0.000237	CcSEcCtD
Idarubicin—Doxorubicin—ABCB1—breast cancer	1.07e-05	0.00734	CrCbGaD
Idarubicin—Dermatitis—Vinorelbine—breast cancer	1.07e-05	0.000237	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—breast cancer	1.06e-05	0.000236	CcSEcCtD
Idarubicin—Urticaria—Fluorouracil—breast cancer	1.06e-05	0.000236	CcSEcCtD
Idarubicin—Headache—Vinorelbine—breast cancer	1.06e-05	0.000236	CcSEcCtD
Idarubicin—Leukopenia—Docetaxel—breast cancer	1.06e-05	0.000235	CcSEcCtD
Idarubicin—Anaemia—Capecitabine—breast cancer	1.06e-05	0.000235	CcSEcCtD
Idarubicin—Body temperature increased—Fluorouracil—breast cancer	1.06e-05	0.000235	CcSEcCtD
Idarubicin—Hypersensitivity—Irinotecan—breast cancer	1.03e-05	0.000229	CcSEcCtD
Idarubicin—Hypersensitivity—Mitoxantrone—breast cancer	1.03e-05	0.000229	CcSEcCtD
Idarubicin—Vomiting—Thiotepa—breast cancer	1.03e-05	0.000228	CcSEcCtD
Idarubicin—Leukopenia—Capecitabine—breast cancer	1.03e-05	0.000228	CcSEcCtD
Idarubicin—Convulsion—Docetaxel—breast cancer	1.03e-05	0.000228	CcSEcCtD
Idarubicin—Rash—Thiotepa—breast cancer	1.02e-05	0.000227	CcSEcCtD
Idarubicin—Dermatitis—Thiotepa—breast cancer	1.02e-05	0.000226	CcSEcCtD
Idarubicin—Headache—Thiotepa—breast cancer	1.01e-05	0.000225	CcSEcCtD
Idarubicin—Chest pain—Docetaxel—breast cancer	1.01e-05	0.000224	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—breast cancer	1.01e-05	0.000224	CcSEcCtD
Idarubicin—Nausea—Vinorelbine—breast cancer	1.01e-05	0.000223	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	1e-05	0.000222	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—breast cancer	9.96e-06	0.000221	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—breast cancer	9.92e-06	0.00022	CcSEcCtD
Idarubicin—Decreased appetite—Paclitaxel—breast cancer	9.91e-06	0.00022	CcSEcCtD
Idarubicin—Hypersensitivity—Fluorouracil—breast cancer	9.87e-06	0.000219	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—breast cancer	9.86e-06	0.000219	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—breast cancer	9.81e-06	0.000218	CcSEcCtD
Idarubicin—Chest pain—Capecitabine—breast cancer	9.76e-06	0.000217	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.7e-06	0.000215	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—breast cancer	9.68e-06	0.000215	CcSEcCtD
Idarubicin—Anaphylactic shock—Docetaxel—breast cancer	9.67e-06	0.000215	CcSEcCtD
Idarubicin—Nausea—Thiotepa—breast cancer	9.62e-06	0.000213	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—breast cancer	9.61e-06	0.000213	CcSEcCtD
Idarubicin—Infection—Docetaxel—breast cancer	9.6e-06	0.000213	CcSEcCtD
Idarubicin—Diarrhoea—Irinotecan—breast cancer	9.57e-06	0.000212	CcSEcCtD
Idarubicin—Diarrhoea—Mitoxantrone—breast cancer	9.57e-06	0.000212	CcSEcCtD
Idarubicin—Shock—Docetaxel—breast cancer	9.51e-06	0.000211	CcSEcCtD
Idarubicin—Thrombocytopenia—Docetaxel—breast cancer	9.46e-06	0.00021	CcSEcCtD
Idarubicin—Skin disorder—Docetaxel—breast cancer	9.39e-06	0.000208	CcSEcCtD
Idarubicin—Gastrointestinal pain—Paclitaxel—breast cancer	9.33e-06	0.000207	CcSEcCtD
Idarubicin—Diarrhoea—Gemcitabine—breast cancer	9.32e-06	0.000207	CcSEcCtD
Idarubicin—Infection—Capecitabine—breast cancer	9.3e-06	0.000206	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—breast cancer	9.22e-06	0.000205	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—breast cancer	9.22e-06	0.000205	CcSEcCtD
Idarubicin—Anorexia—Docetaxel—breast cancer	9.21e-06	0.000204	CcSEcCtD
Idarubicin—Shock—Capecitabine—breast cancer	9.21e-06	0.000204	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—breast cancer	9.18e-06	0.000204	CcSEcCtD
Idarubicin—Diarrhoea—Fluorouracil—breast cancer	9.16e-06	0.000203	CcSEcCtD
Idarubicin—Thrombocytopenia—Capecitabine—breast cancer	9.16e-06	0.000203	CcSEcCtD
Idarubicin—Skin disorder—Capecitabine—breast cancer	9.09e-06	0.000202	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—breast cancer	9.06e-06	0.000201	CcSEcCtD
Idarubicin—Urticaria—Paclitaxel—breast cancer	9.06e-06	0.000201	CcSEcCtD
Idarubicin—Abdominal pain—Paclitaxel—breast cancer	9.02e-06	0.0002	CcSEcCtD
Idarubicin—Body temperature increased—Paclitaxel—breast cancer	9.02e-06	0.0002	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—breast cancer	9e-06	0.0002	CcSEcCtD
Idarubicin—Anorexia—Capecitabine—breast cancer	8.92e-06	0.000198	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—breast cancer	8.9e-06	0.000197	CcSEcCtD
Idarubicin—Vomiting—Irinotecan—breast cancer	8.89e-06	0.000197	CcSEcCtD
Idarubicin—Vomiting—Mitoxantrone—breast cancer	8.89e-06	0.000197	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—breast cancer	8.86e-06	0.000197	CcSEcCtD
Idarubicin—Rash—Mitoxantrone—breast cancer	8.82e-06	0.000196	CcSEcCtD
Idarubicin—Rash—Irinotecan—breast cancer	8.82e-06	0.000196	CcSEcCtD
Idarubicin—Dermatitis—Irinotecan—breast cancer	8.81e-06	0.000195	CcSEcCtD
Idarubicin—Dermatitis—Mitoxantrone—breast cancer	8.81e-06	0.000195	CcSEcCtD
Idarubicin—Chills—Methotrexate—breast cancer	8.8e-06	0.000195	CcSEcCtD
Idarubicin—Headache—Mitoxantrone—breast cancer	8.76e-06	0.000194	CcSEcCtD
Idarubicin—Headache—Irinotecan—breast cancer	8.76e-06	0.000194	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—breast cancer	8.67e-06	0.000192	CcSEcCtD
Idarubicin—Vomiting—Gemcitabine—breast cancer	8.66e-06	0.000192	CcSEcCtD
Idarubicin—Rash—Gemcitabine—breast cancer	8.59e-06	0.000191	CcSEcCtD
Idarubicin—Dermatitis—Gemcitabine—breast cancer	8.58e-06	0.00019	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—breast cancer	8.54e-06	0.000189	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—breast cancer	8.53e-06	0.000189	CcSEcCtD
Idarubicin—Headache—Gemcitabine—breast cancer	8.53e-06	0.000189	CcSEcCtD
Idarubicin—Flushing—Epirubicin—breast cancer	8.52e-06	0.000189	CcSEcCtD
Idarubicin—Vomiting—Fluorouracil—breast cancer	8.52e-06	0.000189	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—breast cancer	8.49e-06	0.000188	CcSEcCtD
Idarubicin—Rash—Fluorouracil—breast cancer	8.44e-06	0.000187	CcSEcCtD
Idarubicin—Dermatitis—Fluorouracil—breast cancer	8.44e-06	0.000187	CcSEcCtD
Idarubicin—Decreased appetite—Docetaxel—breast cancer	8.4e-06	0.000186	CcSEcCtD
Idarubicin—Hypersensitivity—Paclitaxel—breast cancer	8.4e-06	0.000186	CcSEcCtD
Idarubicin—Headache—Fluorouracil—breast cancer	8.39e-06	0.000186	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—breast cancer	8.39e-06	0.000186	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—breast cancer	8.33e-06	0.000185	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—breast cancer	8.32e-06	0.000185	CcSEcCtD
Idarubicin—Nausea—Irinotecan—breast cancer	8.31e-06	0.000184	CcSEcCtD
Idarubicin—Nausea—Mitoxantrone—breast cancer	8.31e-06	0.000184	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—breast cancer	8.29e-06	0.000184	CcSEcCtD
Idarubicin—Chills—Epirubicin—breast cancer	8.23e-06	0.000183	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—breast cancer	8.2e-06	0.000182	CcSEcCtD
Idarubicin—Decreased appetite—Capecitabine—breast cancer	8.14e-06	0.000181	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—breast cancer	8.11e-06	0.00018	CcSEcCtD
Idarubicin—Nausea—Gemcitabine—breast cancer	8.09e-06	0.00018	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—breast cancer	7.99e-06	0.000177	CcSEcCtD
Idarubicin—Nausea—Fluorouracil—breast cancer	7.96e-06	0.000177	CcSEcCtD
Idarubicin—Gastrointestinal pain—Docetaxel—breast cancer	7.9e-06	0.000175	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—breast cancer	7.89e-06	0.000175	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—breast cancer	7.88e-06	0.000175	CcSEcCtD
Idarubicin—Diarrhoea—Paclitaxel—breast cancer	7.8e-06	0.000173	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—breast cancer	7.7e-06	0.000171	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—breast cancer	7.67e-06	0.00017	CcSEcCtD
Idarubicin—Gastrointestinal pain—Capecitabine—breast cancer	7.65e-06	0.00017	CcSEcCtD
Idarubicin—Abdominal pain—Docetaxel—breast cancer	7.64e-06	0.00017	CcSEcCtD
Idarubicin—Body temperature increased—Docetaxel—breast cancer	7.64e-06	0.00017	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—breast cancer	7.64e-06	0.00017	CcSEcCtD
Idarubicin—Chills—Doxorubicin—breast cancer	7.62e-06	0.000169	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—breast cancer	7.59e-06	0.000168	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—breast cancer	7.5e-06	0.000167	CcSEcCtD
Idarubicin—Urticaria—Capecitabine—breast cancer	7.44e-06	0.000165	CcSEcCtD
Idarubicin—Body temperature increased—Capecitabine—breast cancer	7.4e-06	0.000164	CcSEcCtD
Idarubicin—Abdominal pain—Capecitabine—breast cancer	7.4e-06	0.000164	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—breast cancer	7.4e-06	0.000164	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—breast cancer	7.39e-06	0.000164	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—breast cancer	7.38e-06	0.000164	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—breast cancer	7.27e-06	0.000161	CcSEcCtD
Idarubicin—Vomiting—Paclitaxel—breast cancer	7.25e-06	0.000161	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.22e-06	0.00016	CcSEcCtD
Idarubicin—Rash—Paclitaxel—breast cancer	7.19e-06	0.00016	CcSEcCtD
Idarubicin—Dermatitis—Paclitaxel—breast cancer	7.18e-06	0.000159	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—breast cancer	7.15e-06	0.000159	CcSEcCtD
Idarubicin—Headache—Paclitaxel—breast cancer	7.14e-06	0.000159	CcSEcCtD
Idarubicin—Hypersensitivity—Docetaxel—breast cancer	7.12e-06	0.000158	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—breast cancer	6.97e-06	0.000155	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—breast cancer	6.92e-06	0.000154	CcSEcCtD
Idarubicin—Infection—Methotrexate—breast cancer	6.92e-06	0.000154	CcSEcCtD
Idarubicin—Hypersensitivity—Capecitabine—breast cancer	6.9e-06	0.000153	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—breast cancer	6.83e-06	0.000152	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—breast cancer	6.82e-06	0.000151	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—breast cancer	6.8e-06	0.000151	CcSEcCtD
Idarubicin—Nausea—Paclitaxel—breast cancer	6.77e-06	0.00015	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—breast cancer	6.77e-06	0.00015	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.75e-06	0.00015	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—breast cancer	6.64e-06	0.000147	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—breast cancer	6.62e-06	0.000147	CcSEcCtD
Idarubicin—Diarrhoea—Docetaxel—breast cancer	6.61e-06	0.000147	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—breast cancer	6.52e-06	0.000145	CcSEcCtD
Idarubicin—Infection—Epirubicin—breast cancer	6.48e-06	0.000144	CcSEcCtD
Idarubicin—Shock—Epirubicin—breast cancer	6.41e-06	0.000142	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—breast cancer	6.4e-06	0.000142	CcSEcCtD
Idarubicin—Diarrhoea—Capecitabine—breast cancer	6.4e-06	0.000142	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—breast cancer	6.38e-06	0.000142	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—breast cancer	6.33e-06	0.000141	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—breast cancer	6.29e-06	0.00014	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.25e-06	0.000139	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—breast cancer	6.22e-06	0.000138	CcSEcCtD
Idarubicin—Vomiting—Docetaxel—breast cancer	6.15e-06	0.000136	CcSEcCtD
Idarubicin—Rash—Docetaxel—breast cancer	6.1e-06	0.000135	CcSEcCtD
Idarubicin—Dermatitis—Docetaxel—breast cancer	6.09e-06	0.000135	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—breast cancer	6.06e-06	0.000134	CcSEcCtD
Idarubicin—Headache—Docetaxel—breast cancer	6.06e-06	0.000134	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—breast cancer	6.03e-06	0.000134	CcSEcCtD
Idarubicin—Infection—Doxorubicin—breast cancer	5.99e-06	0.000133	CcSEcCtD
Idarubicin—Vomiting—Capecitabine—breast cancer	5.95e-06	0.000132	CcSEcCtD
Idarubicin—Shock—Doxorubicin—breast cancer	5.94e-06	0.000132	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—breast cancer	5.91e-06	0.000131	CcSEcCtD
Idarubicin—Rash—Capecitabine—breast cancer	5.9e-06	0.000131	CcSEcCtD
Idarubicin—Dermatitis—Capecitabine—breast cancer	5.9e-06	0.000131	CcSEcCtD
Idarubicin—Headache—Capecitabine—breast cancer	5.86e-06	0.00013	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—breast cancer	5.86e-06	0.00013	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—breast cancer	5.75e-06	0.000128	CcSEcCtD
Idarubicin—Nausea—Docetaxel—breast cancer	5.74e-06	0.000127	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—breast cancer	5.7e-06	0.000126	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—breast cancer	5.67e-06	0.000126	CcSEcCtD
Idarubicin—Nausea—Capecitabine—breast cancer	5.56e-06	0.000123	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—breast cancer	5.53e-06	0.000123	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—breast cancer	5.51e-06	0.000122	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—breast cancer	5.51e-06	0.000122	CcSEcCtD
Idarubicin—Gastrointestinal pain—Epirubicin—breast cancer	5.33e-06	0.000118	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—breast cancer	5.24e-06	0.000116	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—breast cancer	5.18e-06	0.000115	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—breast cancer	5.15e-06	0.000114	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—breast cancer	5.15e-06	0.000114	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—breast cancer	5.13e-06	0.000114	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—breast cancer	4.93e-06	0.000109	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—breast cancer	4.8e-06	0.000107	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—breast cancer	4.79e-06	0.000106	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—breast cancer	4.77e-06	0.000106	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—breast cancer	4.77e-06	0.000106	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—breast cancer	4.77e-06	0.000106	CcSEcCtD
Idarubicin—Diarrhoea—Epirubicin—breast cancer	4.46e-06	9.9e-05	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—breast cancer	4.44e-06	9.86e-05	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—breast cancer	4.43e-06	9.83e-05	CcSEcCtD
Idarubicin—Rash—Methotrexate—breast cancer	4.39e-06	9.75e-05	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—breast cancer	4.39e-06	9.74e-05	CcSEcCtD
Idarubicin—Headache—Methotrexate—breast cancer	4.36e-06	9.69e-05	CcSEcCtD
Idarubicin—Vomiting—Epirubicin—breast cancer	4.15e-06	9.2e-05	CcSEcCtD
Idarubicin—Nausea—Methotrexate—breast cancer	4.14e-06	9.18e-05	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—breast cancer	4.13e-06	9.16e-05	CcSEcCtD
Idarubicin—Rash—Epirubicin—breast cancer	4.11e-06	9.12e-05	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—breast cancer	4.11e-06	9.11e-05	CcSEcCtD
Idarubicin—Headache—Epirubicin—breast cancer	4.08e-06	9.06e-05	CcSEcCtD
Idarubicin—Nausea—Epirubicin—breast cancer	3.87e-06	8.59e-05	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—breast cancer	3.84e-06	8.51e-05	CcSEcCtD
Idarubicin—Rash—Doxorubicin—breast cancer	3.8e-06	8.44e-05	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—breast cancer	3.8e-06	8.43e-05	CcSEcCtD
Idarubicin—Headache—Doxorubicin—breast cancer	3.78e-06	8.39e-05	CcSEcCtD
Idarubicin—Nausea—Doxorubicin—breast cancer	3.58e-06	7.95e-05	CcSEcCtD
Idarubicin—ABCC1—Disease—ITPR1—breast cancer	2.65e-06	0.000215	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.64e-06	0.000215	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP3A4—breast cancer	2.63e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB4—breast cancer	2.63e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT5A—breast cancer	2.63e-06	0.000214	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.62e-06	0.000213	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HADHB—breast cancer	2.6e-06	0.000211	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPI—breast cancer	2.6e-06	0.000211	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1B1—breast cancer	2.59e-06	0.00021	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.58e-06	0.00021	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPI—breast cancer	2.57e-06	0.000209	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HADHB—breast cancer	2.57e-06	0.000209	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—RAF1—breast cancer	2.57e-06	0.000209	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SMAD4—breast cancer	2.54e-06	0.000207	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HSP90AA1—breast cancer	2.54e-06	0.000206	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HES1—breast cancer	2.48e-06	0.000202	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDH1A1—breast cancer	2.48e-06	0.000201	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDH7A1—breast cancer	2.48e-06	0.000201	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NCOR1—breast cancer	2.47e-06	0.000201	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOA1—breast cancer	2.47e-06	0.000201	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.46e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDH1A1—breast cancer	2.46e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDH7A1—breast cancer	2.46e-06	0.0002	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF1—breast cancer	2.44e-06	0.000198	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—STK11—breast cancer	2.43e-06	0.000198	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP19A1—breast cancer	2.43e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.43e-06	0.000197	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NRG1—breast cancer	2.42e-06	0.000197	CbGpPWpGaD
Idarubicin—ABCC1—Disease—H2AFX—breast cancer	2.41e-06	0.000196	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—FHL2—breast cancer	2.38e-06	0.000193	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UMPS—breast cancer	2.38e-06	0.000193	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADSL—breast cancer	2.38e-06	0.000193	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NME1—breast cancer	2.38e-06	0.000193	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PHGDH—breast cancer	2.38e-06	0.000193	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NME1—breast cancer	2.36e-06	0.000191	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADSL—breast cancer	2.36e-06	0.000191	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—FHL2—breast cancer	2.36e-06	0.000191	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PHGDH—breast cancer	2.36e-06	0.000191	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UMPS—breast cancer	2.36e-06	0.000191	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—breast cancer	2.33e-06	0.00019	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LDHB—breast cancer	2.33e-06	0.000189	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HPSE—breast cancer	2.33e-06	0.000189	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BRIP1—breast cancer	2.33e-06	0.000189	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERCC2—breast cancer	2.32e-06	0.000189	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LDHB—breast cancer	2.31e-06	0.000188	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HPSE—breast cancer	2.31e-06	0.000188	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BRIP1—breast cancer	2.31e-06	0.000188	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.28e-06	0.000186	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB3—breast cancer	2.27e-06	0.000185	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGFR2—breast cancer	2.27e-06	0.000184	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—COMT—breast cancer	2.26e-06	0.000184	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTP1—breast cancer	2.25e-06	0.000183	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HMOX1—breast cancer	2.22e-06	0.00018	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ITPR1—breast cancer	2.22e-06	0.00018	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCC1—breast cancer	2.21e-06	0.000179	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMMR—breast cancer	2.21e-06	0.000179	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA3—breast cancer	2.21e-06	0.000179	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA3—breast cancer	2.19e-06	0.000178	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCC1—breast cancer	2.19e-06	0.000178	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMMR—breast cancer	2.19e-06	0.000178	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTHFR—breast cancer	2.18e-06	0.000177	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TERT—breast cancer	2.18e-06	0.000177	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARGC1B—breast cancer	2.14e-06	0.000174	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCB1—breast cancer	2.13e-06	0.000173	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARGC1B—breast cancer	2.12e-06	0.000172	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGFR1—breast cancer	2.11e-06	0.000172	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TYMS—breast cancer	2.09e-06	0.00017	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—breast cancer	2.08e-06	0.000169	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTM1—breast cancer	2.07e-06	0.000168	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PLA2G4A—breast cancer	2.07e-06	0.000168	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOR1—breast cancer	2.07e-06	0.000168	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.06e-06	0.000168	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.06e-06	0.000168	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CA9—breast cancer	2.02e-06	0.000164	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA4—breast cancer	2.02e-06	0.000164	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CAV1—breast cancer	2.01e-06	0.000164	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA4—breast cancer	2e-06	0.000163	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CA9—breast cancer	2e-06	0.000163	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GPX1—breast cancer	1.98e-06	0.000161	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.98e-06	0.000161	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA2—breast cancer	1.97e-06	0.00016	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPX2—breast cancer	1.97e-06	0.00016	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1A1—breast cancer	1.96e-06	0.000159	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.96e-06	0.000159	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPX2—breast cancer	1.95e-06	0.000159	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA2—breast cancer	1.95e-06	0.000159	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ERCC2—breast cancer	1.95e-06	0.000158	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SULT1A1—breast cancer	1.94e-06	0.000158	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPX4—breast cancer	1.94e-06	0.000158	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SULT1A1—breast cancer	1.93e-06	0.000157	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPX4—breast cancer	1.93e-06	0.000157	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—IDH1—breast cancer	1.9e-06	0.000154	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA1—breast cancer	1.9e-06	0.000154	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS2—breast cancer	1.89e-06	0.000154	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA1—breast cancer	1.88e-06	0.000153	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—IDH1—breast cancer	1.88e-06	0.000153	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NAT2—breast cancer	1.88e-06	0.000153	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOTCH1—breast cancer	1.88e-06	0.000152	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NAT2—breast cancer	1.86e-06	0.000151	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KIT—breast cancer	1.83e-06	0.000149	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APC—breast cancer	1.83e-06	0.000149	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—MTHFR—breast cancer	1.83e-06	0.000149	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGF—breast cancer	1.81e-06	0.000147	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—breast cancer	1.72e-06	0.00014	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CAV1—breast cancer	1.69e-06	0.000137	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.68e-06	0.000137	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT2—breast cancer	1.68e-06	0.000136	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—DPYD—breast cancer	1.65e-06	0.000134	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MED12—breast cancer	1.65e-06	0.000134	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—DPYD—breast cancer	1.63e-06	0.000133	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MED12—breast cancer	1.63e-06	0.000133	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDOA—breast cancer	1.62e-06	0.000132	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CD—breast cancer	1.61e-06	0.000131	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.61e-06	0.000131	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDOA—breast cancer	1.61e-06	0.000131	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SERPINE1—breast cancer	1.59e-06	0.00013	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOA3—breast cancer	1.57e-06	0.000128	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A2—breast cancer	1.56e-06	0.000127	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOA3—breast cancer	1.56e-06	0.000127	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A2—breast cancer	1.55e-06	0.000126	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CG—breast cancer	1.54e-06	0.000125	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.53e-06	0.000125	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CPT1A—breast cancer	1.53e-06	0.000124	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCG2—breast cancer	1.53e-06	0.000124	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTR—breast cancer	1.53e-06	0.000124	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS3—breast cancer	1.52e-06	0.000124	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCG2—breast cancer	1.52e-06	0.000123	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTR—breast cancer	1.52e-06	0.000123	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CPT1A—breast cancer	1.52e-06	0.000123	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HPGDS—breast cancer	1.5e-06	0.000122	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HBA1—breast cancer	1.49e-06	0.000121	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HPGDS—breast cancer	1.49e-06	0.000121	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HBA1—breast cancer	1.48e-06	0.00012	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ACHE—breast cancer	1.46e-06	0.000118	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTT1—breast cancer	1.46e-06	0.000118	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—breast cancer	1.44e-06	0.000117	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ACHE—breast cancer	1.44e-06	0.000117	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTT1—breast cancer	1.44e-06	0.000117	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RAF1—breast cancer	1.44e-06	0.000117	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—breast cancer	1.42e-06	0.000116	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CB—breast cancer	1.41e-06	0.000114	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTOR—breast cancer	1.41e-06	0.000114	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD4—breast cancer	1.4e-06	0.000114	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—breast cancer	1.39e-06	0.000113	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP17A1—breast cancer	1.38e-06	0.000112	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP17A1—breast cancer	1.37e-06	0.000111	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS1—breast cancer	1.36e-06	0.000111	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO1—breast cancer	1.36e-06	0.000111	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO1—breast cancer	1.35e-06	0.00011	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS1—breast cancer	1.35e-06	0.00011	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CD—breast cancer	1.35e-06	0.00011	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.35e-06	0.00011	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALB—breast cancer	1.33e-06	0.000108	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.33e-06	0.000108	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2D6—breast cancer	1.33e-06	0.000108	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1B—breast cancer	1.32e-06	0.000107	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOA2—breast cancer	1.31e-06	0.000107	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOA2—breast cancer	1.3e-06	0.000106	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NOS3—breast cancer	1.28e-06	0.000104	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—FASN—breast cancer	1.27e-06	0.000104	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BCHE—breast cancer	1.27e-06	0.000103	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—FASN—breast cancer	1.26e-06	0.000103	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BCHE—breast cancer	1.26e-06	0.000102	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A5—breast cancer	1.25e-06	0.000102	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CTNNB1—breast cancer	1.25e-06	0.000101	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A5—breast cancer	1.24e-06	0.000101	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1A—breast cancer	1.22e-06	9.89e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—breast cancer	1.21e-06	9.87e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NQO1—breast cancer	1.21e-06	9.83e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A1—breast cancer	1.21e-06	9.83e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A1—breast cancer	1.2e-06	9.75e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NQO1—breast cancer	1.2e-06	9.75e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP3A4—breast cancer	1.18e-06	9.59e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CB—breast cancer	1.18e-06	9.57e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.17e-06	9.55e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP3A4—breast cancer	1.17e-06	9.51e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—breast cancer	1.17e-06	9.48e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.16e-06	9.46e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1B1—breast cancer	1.16e-06	9.43e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1B1—breast cancer	1.15e-06	9.35e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.14e-06	9.25e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.13e-06	9.17e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SRC—breast cancer	1.13e-06	9.15e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOA1—breast cancer	1.11e-06	8.99e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOA1—breast cancer	1.1e-06	8.92e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP19A1—breast cancer	1.09e-06	8.86e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—STK11—breast cancer	1.09e-06	8.86e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—breast cancer	1.09e-06	8.83e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—STK11—breast cancer	1.08e-06	8.79e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP19A1—breast cancer	1.08e-06	8.79e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK3—breast cancer	1.04e-06	8.43e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—breast cancer	1.02e-06	8.27e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.02e-06	8.25e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—COMT—breast cancer	1.01e-06	8.24e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—breast cancer	1.01e-06	8.2e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTP1—breast cancer	1.01e-06	8.2e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFB1—breast cancer	1.01e-06	8.18e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—COMT—breast cancer	1.01e-06	8.17e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTP1—breast cancer	1e-06	8.13e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMOX1—breast cancer	9.95e-07	8.09e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ITPR1—breast cancer	9.93e-07	8.07e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—breast cancer	9.87e-07	8.02e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMOX1—breast cancer	9.87e-07	8.02e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ITPR1—breast cancer	9.85e-07	8e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCB1—breast cancer	9.55e-07	7.76e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCB1—breast cancer	9.47e-07	7.7e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TYMS—breast cancer	9.38e-07	7.62e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KRAS—breast cancer	9.33e-07	7.58e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TYMS—breast cancer	9.3e-07	7.56e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOR1—breast cancer	9.27e-07	7.54e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PLA2G4A—breast cancer	9.27e-07	7.54e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM1—breast cancer	9.27e-07	7.54e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM1—breast cancer	9.19e-07	7.47e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PLA2G4A—breast cancer	9.19e-07	7.47e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOR1—breast cancer	9.19e-07	7.47e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPX1—breast cancer	8.88e-07	7.22e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPX1—breast cancer	8.8e-07	7.16e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1A1—breast cancer	8.79e-07	7.14e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ERCC2—breast cancer	8.72e-07	7.09e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1A1—breast cancer	8.72e-07	7.08e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ERCC2—breast cancer	8.64e-07	7.02e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—breast cancer	8.57e-07	6.96e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTHFR—breast cancer	8.2e-07	6.66e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTHFR—breast cancer	8.13e-07	6.6e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HRAS—breast cancer	7.93e-07	6.44e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6—breast cancer	7.59e-07	6.17e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CAV1—breast cancer	7.56e-07	6.14e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CAV1—breast cancer	7.5e-07	6.09e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—breast cancer	7.18e-07	5.83e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.16e-07	5.82e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—breast cancer	7e-07	5.69e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CG—breast cancer	6.89e-07	5.6e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CG—breast cancer	6.83e-07	5.55e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CD—breast cancer	6.05e-07	4.92e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CD—breast cancer	6e-07	4.88e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALB—breast cancer	5.98e-07	4.86e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALB—breast cancer	5.92e-07	4.81e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—breast cancer	5.86e-07	4.76e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NOS3—breast cancer	5.72e-07	4.65e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NOS3—breast cancer	5.67e-07	4.61e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CB—breast cancer	5.28e-07	4.29e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CB—breast cancer	5.23e-07	4.25e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—breast cancer	5.23e-07	4.25e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—breast cancer	5.18e-07	4.21e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—breast cancer	4.56e-07	3.71e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—breast cancer	4.52e-07	3.67e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—breast cancer	3.22e-07	2.61e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—breast cancer	3.19e-07	2.59e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—breast cancer	2.63e-07	2.14e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—breast cancer	2.61e-07	2.12e-05	CbGpPWpGaD
